Published by Josh White on 21st December 2021
(Sharecast News) - Contract research organisation Open Orphan announced on Tuesday that its subsidiary hVIVO has signed a £5m influenza human challenge study contract with an unnamed biotechnology company, developing an antiviral drug for protection against respiratory viral infections.
URL: http://www.digitallook.com/dl/news/story/32349652/...